BRIEF-Glenmark Pharma gets ANDA approval for olmesartan medoxomil tablets
* Says glenmark Pharmaceuticals receives ANDA approval for olmesartan medoxomil tablets, 5 mg, 20 mg and 40 mg
LONDON May 4 Imagination Technologies said it had started a "dispute resolution procedure" with Apple , its biggest customer, after failing to resolve a standoff over licensing between the two companies.
Imagination said in April that Apple had notified the British firm it was developing its own graphics chips and would no longer use Imagination's processing designs in 15 months to two years time. The news sent shares in the British firm down 70 percent on the day.
It said on Thursday it had commenced the dispute resolution procedure under the licence agreement with a view to reaching an agreement through a more structured process. It also said it planned to sell two businesses, MIPS and Ensigma.
(Reporting by Kate Holton, editing by Paul Sandle)
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_05262017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:00 am: Container Corporation earnings conference call in New Delhi. 5:00 pm: RBI to release weekly foreign exchange data in Mumbai. GMF: LIVECHAT - OPEC REVIEW Gavin Maguire,
May 25 A federal judge ordered United Parcel Service Inc to pay nearly $247 million in damages and penalties for "illegally shipping" large volumes of untaxed cigarettes in New York state and City, a court filing showed on Thursday.